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Release of cetyl pyridinium chloride from fatty acid chelate temporary
dental cement
Andrew Hurta, Nichola J. Colemana, Tamer Tu¨zu¨nerb, Bora Bagisc, Fatih Mehmet Korkmazd
and John W. Nicholsone
aDepartment of Pharmaceutical, Chemical & Environmental Sciences, University of Greenwich, Medway Campus, Chatham, Kent, UK;
bDepartment of Paediatric Dentistry, Faculty of Dentistry, Karadiniez Technical University, Trabzon, Turkey; cDepartment of Prosthodontics,
_Izmir Katip C¸elebi University, Faculty of Dentistry, Izmir, Turkey; dDepartment of Prosthodontics, Faculty of Dentistry, Karadiniez Technical
University, Trabzon, Turkey; eBluefield Centre for Biomaterials, London, UK
ABSTRACT
Objective To determine whether the antimicrobial nature of a fatty acid chelate temporary dental
cement can be enhanced by the addition of 5% cetyl pyridinium chloride (CPC).
Materials and methods The temporary cement, Cavex Temporary was employed, and additions of
CPC were made to either the base or the catalyst paste prior to mixing the cement. Release of CPC
from set cement specimens was followed using reverse-phase HPLC for a period of up to 2 weeks
following specimen preparation. Potential interactions between Cavex and CPC were examined by
Fourier transform infrared spectroscopy (FTIR) and antimicrobial effects were determined using
zone of inhibition measurements after 24 h with disc-shaped specimens in cultured Streptococcus
mutans.
Results FTIR showed no interaction between CPC and the components of the cement. CPC release
was found to follow a diffusion mechanism for the first 6 h or so, and to equilibrate after
approximately 2 weeks, with no significant differences between release profiles when the additive
was incorporated into the base or the catalyst paste. Diffusion was rapid, and had a diffusion
coefficient of approximately 1 109m2 s1 in both cases. Total release was in the range 10–12%
of the CPC loading. Zones of inhibition around discs containing CPC were significantly larger than
those around the control discs of CPC-free cement.
Conclusions The antimicrobial character of this temporary cement can be enhanced by the
addition of CPC. Such enhancement is of potential clinical value, though further in vivo work is
needed to confirm this.
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Introduction
The incorporation of antimicrobial compounds into
dental restorative materials is a subject that is being
increasingly studied.[1] It was not necessary for silver
amalgam, because this material is inherently antimicro-
bial, but it has been studied for both dental composite
resins [2–6] and glass-ionomer cements.[7–11] In both
cases, the aim has been to release the antimicrobial
substance in a controlled way to inhibit or kill micro-
organisms that make up the oral biofilm.
For composite resins, a typical study involved chlor-
hexidine,[3] which was incorporated into the material at
levels of a few percent by mass, and found to be
successful in inhibiting microbial growth. However, it
proved to be effective for short periods only.[3] It also
had the disadvantage of leaving behind micro-voids in
the resin structure, and these adversely affected the
mechanical properties of the material.[2,4]
Silver has also been used as an antimicrobial agent in
composite resins. It was introduced to the material as
part of a silica glass filler [5] and was found to leach at
concentrations that made it effective against
Streptococcus mutans and related species.[6] There was
no adverse effect on mechanical properties using this
approach but the antimicrobial effect was also of a
somewhat limited duration.[5] Also, the silver released
had an adverse effect on the color of the composite.[12]
On balance, it, therefore, appears that organic anti-
microbial compounds give more favorable results in
composite resins.
Glass-ionomers have also been studied for the
incorporation of antimicrobial compounds.[7–11] They
CONTACT Professor John W. Nicholson john.nicholson@bluefieldcentre.co.uk Bluefield Centre for Biomaterials, 67-68 Hatton Garden, London
EC1N 8JY, UK
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(http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is
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possess some slight antimicrobial properties even in the
absence of additives, due to their ability to release
fluoride.[13] In principle, fluoride is toxic toward micro-
organisms, since it deactivates enzymes that contain
magnesium by forming the insoluble compound
MgF2.[14] However, the effect is slight with clinical
glass-ionomers because the level of release is low.[15]
Chlorhexidine compounds have been added to glass-
ionomers and successfully promoted antimicrobial char-
acter. For example, chlorhexidine gluconate has been
added and shown to enhance antimicrobial activity.[16]
Chlorhexidine diacetate has also been shown to be
effective,[7] with increased antimicrobial properties
being determined for up to 50 days. A number of
other antimicrobial compounds have been found to be
effective in improving the antimicrobial character of
glass-ionomers, including cetyl pyridinium chloride
(CPC),[17] cetrimide,[17] benzalkonium chloride [17]
and tri-sodium citrate.[18] Mixtures of chlorhexidine
diacetate and cetrimide have also been used, with
promising results.[19]
The difficulty with all of these additives is their
tendency to slow down the setting reaction of the glass-
ionomer cement, to weaken the set cement [7,17] and
reduce its hardness.[8] Nonetheless, significant improve-
ments in antimicrobial character have been demon-
strated and these may be of importance clinically.
To date, there have been no studies which include
antimicrobial compounds in temporary cements. In
these materials, a relatively short-term release might be
acceptable, and could improve clinical outcomes where
temporary cements are required prior to the permanent
fitting of crowns and bridges with more durable cements.
One material of interest is the chelate cement formed
from fatty acids with metal salts, and this is the subject
of the present study. The antimicrobial compound CPC
has been added to either the base or the catalyst paste,
cement specimens prepared and release profiles deter-
mined. Potential chemical interactions between the
cement and CPC were also investigated by Fourier
transform infrared spectroscopy (FTIR).
Materials and methods
The study employed a commercial temporary cement,
Cavex Temporary (Cavex BV, Haarlem, Netherlands), a
eugenol-free fatty acid chelate cement based on zinc
oxide. The antimicrobial compound used was CPC
(Sigma Aldrich, St. Louis, Missouri, United States). The
cement was mixed according to the manufacturer’s
instructions at a ratio of 1 g of ‘‘base’’ paste to 0.5 g of
‘‘catalyst’’ paste. Mixing was performed on a glass plate
using a metal spatula.
Two series of specimens were prepared, each com-
prising three samples. In one, CPC was added to the base
paste; in the other it was added to the catalyst. In both
cases, the amount added corresponded to 5% by mass of
finished paste.
Freshly mixed pastes were transferred to silicone
rubber molds and placed between glass microscope
slides. Finished specimens were of size 6mm diameter
by 2mm depth. They were allowed to cure fully in the
molds at 37 C for 1 h, then placed in 5 cm3 volumes of
deionized water in polypropylene tubes. They were
stored at 37 C, then at designated time periods (1 h, 2 h,
3 h, 6 h, 24 h, 1 week, 2 weeks) a volume of 0.1 cm3 was
removed from the storage solution and placed in a glass
HPLC vial for analysis.
Concentrations of CPC released at various time
intervals were determined by HPLC using an Agilent
1200 series chromatograph (Santa Clara, California,
United States) fitted with a reverse-phase C-18 Primsep
column of length 150mm 4.60mm. Analysis used a
20-ml injection volume, at a flow rate of 1.0 cm3/min,
with an isochratic mobile phase consisting of 55:45
acetonitrile–water with an added drop of concentrated
sulfuric acid. Detection was by means of a variable
wavelength detector set to 259 nm.
Once release had equilibrated, data were converted to
values of Mt/M1 and plotted against square root of time,
t½, to give a straight line whose slope was used to
determine the diffusion coefficient. The best-fit line was
determined by least-squares regression, and differences
in release data and diffusion coefficients were tested for
significance using the Student t-test.
Attenuated total reflectance (ATR) FTIR spectra were
obtained for cement components and for Cavex discs
which had been cured for 24 h using a Perkin Elmer
Spectrum One spectrometer (Waltham, Massachusetts,
United States) with a Universal Diamond ATR attach-
ment. Data were collected between 650 and 4000 cm1
with 10 accumulated scans at a resolution of 2 cm1.
The antimicrobial activities of the Cavex cement alone
and of the cement with 5% CPC mixed into the base
were evaluated using the semi-quantitative Kirby–Bauer
inhibition zone method. The micro-organism employed
was S. mutans NCIMB 13700, a Gram-positive bacter-
ium. 100 cm3 of Nutrient Broth (Oxoid) was inoculated
with 0.1 cm3 of an overnight culture of the bacterium.
The culture was then incubated for 24 h, with shaking, at
37 C. 0.2 cm3 of the resulting culture was spread in
triplicate on nutrient agar plates. Two 6-mm cement
discs were placed on each spread plate. After incubation
at 37 C for 24 h, the plates were examined for clear
zones. Plate counts indicated that the final population
density of the spread plates was 1.5 (±0.7) 108 colony
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forming units per plate. A one-tailed t-test (at p¼ 0.01)
was used to determine any statistical difference between
the antimicrobial activities of the cement specimens with
and without 5% CPC.
Results
All samples were found to release CPC at all time
intervals. After 2 weeks, release had equilibrated. Typical
release profiles for CPC are shown in Figures 1 and 2 for
base-added and catalyst-added, respectively.
Release profiles were recalculated to determine values
of Mt/M1 and diffusion plots of Mt/M1 versus t
½ are
shown in Figures 3 and 4. Diffusion coefficients were
determined from the slope of these plots using the so-
called Stefan approximation, i.e. substituting into the
equation:
D ¼
s
2
l
2
4
,
where s is the slope of the diffusion plot and l is the
specimen thickness.
Release data are shown in Table 1. There were no
significant differences between any of the values in this
table, showing that release of CPC did not alter when the
additive was incorporated into either the base or the
catalyst component prior to mixing the overall cement.
FTIR spectra of cement with and without 5% CPC are
shown in Figure 5, and assignments of bands in Table 2.
No new bands appeared and none of the original bands
were shifted by the presence of CPC, suggesting that
there is no interaction between the cement components
and CPC.
The antimicrobial effect of CPC released from Cavex
discs is shown by the results in Table 3. The zone of
Figure 1. Representative release profile for cement with CPC
added to base.
Figure 2. Representative release profile for cement with CPC
added to catalyst.
Figure 4. Diffusion plot (Mt/M1 vs. t
½) for cement with CPC
added to catalyst.
Figure 3. Diffusion plot (Mt/M1 vs. t
½) for cement with CPC
added to base.
Table 1. Release characteristics for CPC eluted from temporary
cement added by incorporating into base or catalyst component
(standard deviations in parentheses).
Property Base-added Catalyst-added
Equilibrium concentration (ppm) 148.3 (11.5) 167.9 (13.0)
Proportion released (%) 10.4 (0.8) 11.7 (0.9)
Diffusion coefficient (m2 s1) 1.16 109
(0.05 109)
1.11 109
(0.12 109)
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inhibition was much larger in the discs formulated with
CPC, and the t-calc value was greater than the t-crit
value at p¼ 0.01, demonstrating that this difference was
significant, and that sufficient CPC was released from the
Cavex discs to inhibit the growth of the S. mutans
culture.
Discussion
FTIR spectroscopy showed that there was no chemical
reaction between the components of the fatty acid
chelate cement and CPC. For example, the band at
1637 cm1 due to the nitrile (CN) group was visible in
the spectra of the mixtures, showing that this functional
group had not undergone a reaction. It occurred as a
shoulder on the C–C stretching band of Cavex centered
at 1577 cm1, and could not be resolved further.
Nonetheless, its appearance was clear enough to show
the presence of the functional group, and hence to rule
out a possible reaction. Overall, FTIR results confirmed
in that there were no differences between the additive-
free cement and the ones containing CPC, and this
showed that CPC can be included without altering the
essential properties of the cement.
Release of CPC from the cement was shown to occur
by diffusion for the first 6 h or so, and to continue for
several days until equilibrating after approximately 2
weeks. This behavior is similar to the release of a number
of substances from composite resins and dental
cements,[20] including sodium fusidate from glass-
ionomer [21] and benzalkonium chloride from zinc
polycarboxylate.[22] Although diffusion appears to be
the most straightforward of the possible release mech-
anisms, it is not followed in all cases and, for example,
the release of gentamycin from acrylic bone cement in
orthopedics does not have this release mechanism.[23]
Release by diffusion can occur with a wide range of
diffusion coefficients. The values, we have found in the
present study are relatively high, being around
1 109m2 s1 and these were not influenced by
whether the CPC was incorporated into the base or
the catalyst component. Sufficient CPC was released to
have a clear and significant effect on cultured S. mutans,
as demonstrated by the much greater zones of inhibition
around specimens containing CPC.
CPC was chosen for these studies because it is a useful
broad-spectrum antimicrobial compound and is used in
a variety of oral healthcare products, including mouth-
rinses.[24] Although it has a very low level of toxicity
toward humans, oral care products typically contain such
levels that there are no concerns over toxicity.[25]
Rather, the only drawbacks appear to be the possible
staining of the tongue and teeth of the patient, following
Figure 5. FTIR spectra for cement components with and
without CPC.
Table 2. FTIR assignments for the components of cavex
temporary cement and CPC.
Assignment Cavex (cm1) CPC (cm1)
Cavex and 5%
CPC (cm1)
C–H bend 689
C–H bend 716
C–H bend 784
C–O stretch 1083 1086
C–O stretch 1175 1178
C–N stretch 1179
C–H bend 1377 1377
C–H bend 1457 1472 1459
C¼ C aromatic stretch
C–C stretch 1577 1574
C¼N stretch 1637
COOH stretching 1738 1739
C–H stretching 2851 2849 2850
C–H stretching 2920 2913 2918
OH stretching 3373 3371
Table 3. Inhibition zone data for cavex and CPC-cavex discs.
S. mutans Cavex CPC-Cavex
Zone of inhibition (mm) 0.80 ± 1.09 2.8 ± 0.837
n 6
t-calculated 3.57
t-critical (p¼ 0.01) 3.36
t-calc4t-crit which indicates a significant difference at p¼ 0.01.
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long-term use, and these are not considered severe from
the medical point of view.[25] Levels of CPC of only
0.05% are sufficient to be effective against normal oral
flora [24] and the substance is considered safe for
inclusion in oral hygiene cosmetic products up to levels
of 0.5%.[26] Release levels in our experiments were well
below this, not exceeding 200 ppm, which is equivalent
to 0.02%. We, therefore, do not anticipate any problems
for patients at the levels of CPC that we have used.
In dental materials, CPC does not necessarily have to
be released to be effective. In one study, it was
immobilized in an adhesive, where it showed an
inhibitory effect on bacteria in contact with its sur-
face.[27] However, in the present study, it was clearly
released, and was observed to have an antimicrobial
effect some distance away from discs of chelate cement
in which it was included. Cationic surfactants, such as
CPC, are particularly useful antimicrobials because
bacteria do not appear to develop resistance to them
due to their nonspecific mode of action.[28]
There are more than 700 types of bacteria that have
been reported as capable of occurring in the oral
cavity.[29] S. mutans was used in the present study
because it is a particularly common oral bacterium. It has
been widely reported, and other species of the
Streptococcus genus have also been found, including S.
oralis, S. mitis and S. constellatus.[30] These species
typically occur as part of a biofilm that adheres strongly
to surfaces within the mouth and such biofilms are
known to contribute to the conditions of dental caries
[31] and periodontal disease.[32]
A broad-spectrum antimicrobial, such as CPC, has the
potential to deal with any of these micro-organisms that
occur in the vicinity of a restoration, whether permanent
or temporary. Indeed, the relatively short duration of the
release of this substance from the fatty acid chelate
cement in the current study, and from other cements
previously reported [20] suggests that it is particularly
suited for temporary materials. As such, our findings
indicate that this system has the potential to be beneficial
in clinical situations in maintaining a relatively bacteria-
free region in close proximity to the temporary repair,
thus eliminating further damage due to caries.
Conclusion
The antimicrobial compound CPC has been shown to be
capable of being included at satisfactory levels from a
commercial fatty acid chelate temporary cement without
affecting the setting reaction, and to be released by a
diffusion process. Overall release levels represented 10–
12% of the initial antimicrobial loading, and did not
differ significantly when the additive was incorporated
into the base or the catalyst paste. Diffusion coefficients
were of the order of 1 109m2 s1 and also did not
differ significantly when pre-mixed with either the base
or the catalyst. Microbiological results show that release
occurs at useful levels. Overall, temporary cements with
added CPC have the potential to be clinically beneficial
and act to reduce infection in the oral environment
adjacent to the site of clinical treatment, however, further
in vivo work is necessary to demonstrate this
conclusively.
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